Literature DB >> 10733109

Double-blind crossover study of sacral nerve stimulation for fecal incontinence.

C J Vaizey1, M A Kamm, A J Roy, R J Nicholls.   

Abstract

PURPOSE: Patients with fecal incontinence not amenable to simple repair may have to undergo major reconstructive surgery or resort to a stoma. Sacral nerve stimulation is an alternative approach that may diminish incontinence by altering sphincter and rectal motor function. This study is the first double-blind trial examining the effectiveness of this therapy.
METHODS: Two patients with passive fecal incontinence who had been implanted for nine months with a permanent sacral nerve stimulator and electrode were studied using fecal incontinence diaries, anorectal physiological tests, and quality-of-life assessments (SF-36 health survey). The trial period consisted of two two-week periods, with the stimulator turned on for two weeks and off for two weeks. The main investigator and the patients were blinded to the status of the stimulator.
RESULTS: There was a dramatic difference between the number and severity of episodes of incontinence when the stimulator was turned on vs. turned off (Patient 1, 20 vs. 2 episodes; Patient 2, 4 vs. 0 episodes; off vs. on). There was an increase in squeeze pressure (Patient 1, 70 vs. 100 cm H2O; Patient 2, 60 vs. 90 cm H2O; off vs. on), with moderate increases in resting pressure and rectal threshold and urge volumes. Quality-of-life measurements showed a marked improvement prestimulation vs. nine months after permanent stimulation.
CONCLUSIONS: There is a marked, unequivocal improvement in symptoms of fecal incontinence with sacral nerve stimulation shown in this double-blind crossover trial. Sacral nerve stimulation improves the quality of life in selected patients with fecal incontinence.

Entities:  

Mesh:

Year:  2000        PMID: 10733109     DOI: 10.1007/bf02258292

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  24 in total

1.  Meta-analysis: sacral nerve stimulation versus conservative therapy in the treatment of faecal incontinence.

Authors:  Emile Tan; Nye-Thane Ngo; Ara Darzi; Michael Shenouda; Paris P Tekkis
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

2.  Electrifying progress for fecal incontinence.

Authors:  Lawrence R Schiller
Journal:  Curr Gastroenterol Rep       Date:  2004-10

3.  Optimizing electrode implantation in sacral nerve stimulation--an anatomical cadaver study controlled by a laparoscopic camera.

Authors:  N C Buchs; J-C Dembe; J Robert-Yap; B Roche; J Fasel
Journal:  Int J Colorectal Dis       Date:  2007-08-18       Impact factor: 2.571

4.  Sacral nerve stimulation induces changes in the pelvic floor and rectum that improve continence and quality of life.

Authors:  Susanne Dorothea Otto; Stefanie Burmeister; Heinz J Buhr; Anton Kroesen
Journal:  J Gastrointest Surg       Date:  2010-04       Impact factor: 3.452

5.  Poor outcome of sphincter repair: an evacuation problem?

Authors:  H B Michelsen; P Christensen; S Buntzen; S Laurberg; K Krogh
Journal:  Tech Coloproctol       Date:  2010-10-30       Impact factor: 3.781

6.  Fecal Incontinence.

Authors:  Ronald Fogel
Journal:  Curr Treat Options Gastroenterol       Date:  2001-06

7.  Preliminary results of peripheral transcutaneous neuromodulation in the treatment of idiopathic fecal incontinence.

Authors:  M Queralto; G Portier; P H Cabarrot; G Bonnaud; J P Chotard; M Nadrigny; F Lazorthes
Journal:  Int J Colorectal Dis       Date:  2005-12-06       Impact factor: 2.571

8.  Sacral nerve stimulation for the treatment of fecal incontinence.

Authors:  Scott A Brill; David A Margolin
Journal:  Clin Colon Rectal Surg       Date:  2005-02

9.  Efficacy of cyclic sacral nerve stimulation for faecal incontinence.

Authors:  S Norderval; C Behrenbruch; R Brouwer; J O Keck
Journal:  Tech Coloproctol       Date:  2013-03-23       Impact factor: 3.781

10.  Management of Fecal Incontinence in Children Without Functional Fecal Retention.

Authors:  Licia Pensabene; Samuel Nurko
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.